IBT Bioservices is the contract research division of Integrated BioTherapeutics, Inc. (IBT). IBT Bioservices offers a strong client-oriented research and development service focused on our area of expertise, infectious diseases. Our team has extensive experience in antiviral and antibacterial screening and model development.
M. Javad Aman, PhD
Javad leads IBT and its innovative science programs. He is a distinguished researcher in viral and bacterial diseases with 125+ publications.
Rick Holtsberg, PhD
Rick leads IBT Bioservices’ assay & protein services group and develops IBT’s biochemical reagent portfolio. See Rick’s publications.
Robin leads IBT Bioservices with its state-of-the-art infectious disease research capabilities and strong customer service focus.
Agnes Chenine, PhD
Rajan Adhikari, PhD
Rajan investigates bacterial pathogens and leads antibacterial vaccine and therapeutic development programs. See Rajan’s publications.
Sergey Shulenin, PhD
Sergey works on assay development and protein expression. See Sergey’s publication’s.
Hong leads IBT’s assay development, quality control testing and provides logistical support for IBT’s research and bioservice projects. See Hong’s publications.
Tom works on protein expression and custom scientific projects. See Tom’s publications.
Shweta Kailasan, PhD
Shweta leads IBT’s discovery program for antiviral and antibacterial vaccine & antibody therapeutics. Read Shweta’s publications.
Aru Venkatasubrananiam, PhD
Aru leads IBT’s Chemistry Manufacturing Controls activities in vaccine formulation, development of analytics and animal potency models. See Aru’s publications.
Jackie provides strategic project management support for IBT programs and collaborations.
Haimi leads IBT Bioservices’ strategic growth, marketing and customer management team.